Displaying 101 - 120 of 1946
FTC, DOJ, and HHS Extend Comment Period on Cross-Government Inquiry on Impact of Corporate Greed in Health Care
FTC Expands Patent Listing Challenges, Targeting More Than 300 Junk Listings for Diabetes, Weight Loss, Asthma and COPD Drugs
FTC, DOJ Submit Joint Comment to FERC Warning of Common Ownership Competition Risks in the Public Utilities Industry
Oral Statement of Commissioner Melissa Holyoak
FTC Announces Rule Banning Noncompetes
Fact Sheet on FTC’s Proposed Final Noncompete Rule
FTC Moves to Block Tapestry’s Acquisition of Capri
FTC Approves Modifications to Horseracing Integrity and Safety Authority’s Registration Rule
Federal Agencies Launch Portal for Public Reporting of Anticompetitive Practices in the Health Care Sector
FTC Announces Special Open Commission Meeting on Rule to Ban Noncompetes
EU-US Hold Fourth Joint Technology Competition Policy Dialogue
Stem Cell Institute of America, LLC
In August 2021, the FTC and the Georgia Attorney General’s Office sued the co-founders of the Stem Cell Institute of America for marketing stem cell therapy to seniors nationwide using bogus claims that it is effective in treating arthritis, joint pain, and a range of other orthopedic ailments.
FTC Statement on Amendment to Global Partners, Gulf Oil Acquisition
Displaying 101 - 120 of 1946